We are live on ! Find out more
ABPI

Accentia Biopharmaceuticals
ABPI

Delisted

ABPI was delisted on the 3rd of November, 2008.

Back to rankings

2 hedge funds and large institutions have $135 invested in Accentia Biopharmaceuticals in 2014 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

187% more capital invested

Capital invested by funds: $47 → $135 (+$88)

0% more funds holding

Funds holding: 2 → 2 (0)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Highlander Capital Management
New Jersey
$135 – – –

ABPI Hedge Fund Activity: Q1 2014 in Review

2 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Accentia Biopharmaceuticals (ABPI) for Q1 2014, worth a combined $135 — up 187% from $47 a quarter earlier.

Fund positioning in ABPI was balanced in Q1 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Accentia Biopharmaceuticals (ABPI) as of Q1 2014, unchanged from Q4 2013.
  • Funds reported $135 of Accentia Biopharmaceuticals stock for Q1 2014, up 187% quarter-over-quarter.
  • 0 funds opened new Accentia Biopharmaceuticals positions in Q1 2014 and 0 closed out.

Based on aggregated 13F filings for Q1 2014.